BNO
Click for more information
0.00% 1.0¢ bionomics limited

Analyst report says Buy

  1. windshift
    1,032 Posts.
    lightbulb Created with Sketch. 145
    clock Created with Sketch.
    22/08/17
    16:24
    Post #: 26668149
    BNO has posted a report by H C Wainright & Co. The report rates the stock as a buy. Big price target estimate is provided and speaks about the oncology assets as business development products with the focus ever increasingly turning to BNC210 (probably quite rightly so). It's worth a look. I guess the analyst's price target of $2 is going to make most holders happy. GLTA
    BNO Price at posting: 45.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 6  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

DEG De Grey sees more production at Hemi with latest drilling at Crow, Aquila
right-arrow Created with Sketch.
NEWS Training with professional athletes: How to invest like the best
right-arrow Created with Sketch.
NVA Nova locks in NASDAQ US market listing at a value of only US$3.3M as ASX gets quieter and quieter
right-arrow Created with Sketch.
ABY Adore Beauty appoints former David Jones exec as new CEO
right-arrow Created with Sketch.
MTL Mantle Minerals' Nick Poll talks to HotCopper on finding gold grades up to 3.57g/t at Mt Berghaus
right-arrow Created with Sketch.
BC8 Black Cat Syndicate one pour away from being rerated as producer
right-arrow Created with Sketch.
watchlist Created with Sketch. Add BNO (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.